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A new method for the crystallization of proteins was developed. Saturated solutions of a protein for crystal- 
lization are prepared by chromatography of adsorbed proteins from an insoluble polysaccharide matrix us- 
ing gradients with decreasing ionic strength, decreasing concentration f organic solvents or an appropriate 
shift in pH. Insulin, achymotrypsin and lysozyme for which the X-ray crystal structures are known, were 
crystallized by this method. X-ray diffraction photographs were taken to demonstrate he quality of the 
crystals. In addition to this analytical application, the method may be useful for the crystallization and the 
simultaneous purification of larger amounts of proteins. 
Protein crystallization a-Chymotrypsin Lysozyme 
1. INTRODUCTION 
The traditional methods and reagents for the 
crystallization of biological macromolecules have 
been described by MC Pherson [ 11. The most com- 
monly used techniques are the introduction of 
precipitating agents into aqueous buffered solu- 
tions of the macromolecules via vapour phase or 
liquid phase diffusion. Selection of the most 
favourable conditions for the crystallization of a 
given protein or other macromolecule is tedious 
and time-consuming and depends not only on the 
knowledge of the properties of macromolecules 
but also on the proper matching of numerous other 
parameters necessary for crystallization. The selec- 
tion of appropriate conditions is usually further 
hampered by difficulties in reproducing ex- 
periments when material-saving micromethods 
have to be used. Here we present a new approach 
which allows the selection of crystallization 
parameters during the continuous process based on 
reverse-gradient chromatography on polysac- 
charide gels. This approach is exemplified for 
lysozyme [2], a-chymotrypsin [3,4] and insulin [5], 
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which have previously been crystallized 
structure determined by X-ray analysis. 
2. MATERIALS AND METHODS 
and their 
Lysozyme from hen egg white was purchased 
from Sigma (St. Louis, MO), porcine insulin was 
from ‘Polfa’ (Tarchomin, Poland), a-chymotryp- 
sin from bovine pancreas was from Koch-Light 
Laboratories (Suffolk, England), Sepharose 4B 
and Sephadex G-25 were the products of Pharma- 
cia (Uppsala, Sweden). Polyethylene glycol of M, 
6000 (PEG-6000) and 2-methyl-2,4-pentanediol 
(MPD) were from Serva, Feinbiochemica (Heidel- 
berg, FRG). Isopropanol and ammonium sulphate 
were from Merck (Darmstadt, FRG). All other 
reagents were of analytical grade and purchased 
from POCH (Gliwice, Poland). Saturated salt 
solutions were prepared at 22°C. Their dilution is 
given as a percent related to total saturation 
(10%). 
3. RESULTS AND DISCUSSION 
Proteins and nucleic acids can be precipitated 
from aqueous solutions by salting-out with in- 
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creasing ionic strength. In the presence of water- 
insoluble polysaccharides alting-out results in a 
precipitation of the macromolecules on the 
polymer surface [6,7]. The reverse solubilization 
can be achieved by a gradual decrease of the ionic 
strength in the elution buffer. This principle 
previously applied for purification of proteins [7] 
and nucleic acids [6] is utilized in this work to 
prepare saturated solutions of proteins for 
crystallization. In extension of the previous work, 
in which mainly changes in ionic strength were 
used to elute the proteins, we also used shifts in 
both pH and the concentration of organic solvents 
to achieve elution of the saturated protein solu- 
tions for crystallization experiments. 
For the crystallization of lysozyme a Sepharose 
4B chromatography column was used, The enzyme 
could be precipitated on a column with different 
precipitating agents. Either NaCl, isopropanol, 
PEG-6000 or MPD was used at different pH con- 
ditions. The amount of lysozyme adsorbed on the 
column was varied as well. An example of lyso- 
r 
. 
b 
fractm 
Fig.1. Crystallization of lysozyme. A Sepharose 4B 
column (0.5 x 5.7 cm) was equilibrated with 11% 
saturated NaCl in 20 mM Tris/HCl buffer, pH 7.5, 
containing 10 mM MgClz. Lysozyme (1 mg in IO,& 
buffer) was applied to the column and 10 pl of the same 
buffer with 22% saturated NaCl was added. The 
precipitated protein was eluted with a linear gradient 
from 11% saturated to 0% NaCI (2 x 3.5 ml). Fractions 
of 250~1 were collected in glass tubes at a flow rate of 
5 ml/h. (a) Crystallization of the protein occurred 
to 8% - (-) - (-) - (-) 
52% MPD - (-) - (-) - (-) 
20% PEG-6000 + (+) - t-) + (+) 
A column of Sepharose 4B (0.5 x 5.7 cm) was 
equilibrated with a buffer containin 20 mM Tris/HCI, 
or 50 mM sodium citrate, pH 4.8 (data in parentheses), 
10 mM MgCls and precipitating agents in indicated 
concentration. A gradient (2 x 3.5 ml) up to 0% of the 
precipitating agent was applied. 2.50~1 fractions were 
collected. The crystallization of the fraction with highest 
protein concentration is indicated. + , good crystals; - , 
within 2-3 days at room temperature. no crystals or microcrystalline precipitate 
zyme crystallization after its elution from a 
Sepharose 4B column on an NaCl reverse linear 
gradient is shown in fig. 1. The peak of lysozyme 
appears at 8.6% saturation of NaCI. The concen- 
tration of the protein in this fraction corresponds 
approximately with the turbidity point which was 
independently determined for each precipitating 
agent. At this doncentration of NaCl (tubes 8-10) 
crystallization of lysozyme occurs. The results of 
more systematic studies of the lysozyme 
crystallization are summarized in table 1. Using the 
chromatographic procedure to prepare saturated 
protein solutions, the crystals formed at pH 4.8 
and pH 7.5, provided NaCI or PEG-6000 were 
used as precipitating agents. The crystallization 
was not dependent on the concentration of lyso- 
zyme and took place in 2-3 days at room 
temperature. In the case of isopropanol as 
precipitating agent crystals were observed only at 
pH 7.5. Crystals did not grow in either acidic or 
neutral pH if ammonium sulphate or MPD were 
used for precipitation. 
The crystallization of insulin was achieved by 
chromatography on Sephadex G-25. This material 
is more stable in acidic solutions and at elevated 
temperatures compared to the Sepharose matrix. 
Table 1 
Crystallization of lysozyme from various eluates of 
Sepharose 4B columns 
Gradient 
starting from 
Amount of lysozyme (mg) 
1.0 2.5 5.0 
NaCl saturated to 11% + (+) + (+) + (+) 
38% isopropanol + (-) + (-) + (-) 
(NH&S04 saturated 
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The protein was precipitated at pH 6.4 and then 
eluted from the column at 50°C by a pH gradient 
from pH 6.4 to pH 5.4 (fig.2). The insulin- 
saturated solutions were then treated with ZnS04, 
placed in a thermos flask at 50°C and slowly 
cooled. Crystallization occurred in 2 or 3 fractions 
after 18 h. The variation of sodium citrate buffer 
concentration in the range between 100 and 
150 mM did not have any effect on the crystalliza- 
tion of the insulin. The experiment in fig.2 
demonstrates, in addition, that the principle of 
reversed-gradient chromatography, using solutions 
of decreasing ionic strength [7], can be extended to 
variation of pH at constant salt concentration. 
Protein precipitation on a Sephadex G-25 col- 
umn by addition of an organic solvent and its elu- 
tion by decreasing a gradient of isopropanol is 
Fig.3. Crystallization of cu-chymotrypsin. The same 
column of Sephadex G-25 as described in fig.2 was used. 
cu-Chymotrypsin (1.05 mg in 50 ~1 of 50 mM Tris/HCl, 
pH 6.8) applied to the column which was previously 
equilibrated with the same buffer containing 38% 
isopropanol at room temperature. The column was 
washed with a linear gradient of isopropanol from 38 to 
0% (2 x 3.5 ml) in the same buffer. Absorbance at 
280 nm was monitored. Fractions of 200 pl were 
collected and stored at 15°C. The protein crystallized 
after three days (0). Similar results were obtained under 
analogous conditions using a linear gradient of MPD 
and ammonium sulfate in the above buffer. In these 
cases the concentration boundaries of the precipitating 
agents were 45 to 0% and 44 to O%, respectively. 
Fig.2. Crystallization of insulin. A jacketed column of 
Sephadex G-25 was equilibrated with 50 mM sodium 
citrate buffer, pH 6.4, at 50°C. Insulin solution 
(1.25 mg) in 50 ~1 of 30 mM HCl was applied to the 
column and additional 50~1 of 50 mM sodium citrate, 
pH 6.4, were added to achieve a quantitative 
precipitation of the protein. Elution was performed with 
a linear gradient of 2 x 3.5 ml from 50 mM sodium 
citrate, pH 6.4, to 50 mM sodium citrate, pH 5.4. 
Fractions of 200~1 were collected at a flow rate of 
6 ml/h. To protein-containing fractions 5 pl of 75 mM 
ZnS04 was added. These fractions were put into a 
thermos flask at 50°C and slowly cooled. After 18 h the 
crystals started to occur (0). No differences were 
observed by variation of the sodium citrate 
concentration in the elution buffer in the range between 
100 and 150 mM. 
demonstrated for cu-chymotrypsin in fig.3. The 
protein was eluted as a single peak and in fractions 
of the highest protein concentration, crystals 
formed within 3 days at room temperature. The 
crystallization was not dependent on the amount 
of protein applied to the column. The concentra- 
tion of the organic solvent in the corresponding 
fraction is the most important parameter which 
determines the crystallization process. Similar 
results were obtained for MPD and ammonium 
sulfate, when used for the precipitation of the pro- 
tein. Here, however, gradients from 45 to 0% 
MPD and 44% saturation of ammonium sulfate 
were utilized to achieve the elution and crystalliza- 
tion of the protein. 
In all cases the crystals formed were analysed by 
taking X-ray diffraction photographs, which were 
compared with published data [2-51. 
4. CONCLUSIONS 
We have demonstrated that crystallization of 
proteins can be combined with a common purifica- 
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tion procedure using reverse-salt-gradient chrorna- 
tography. Saturated solutions of proteins can be 
produced by this method under very mild and 
reproducible conditions. An oversaturation 
leading to formation of an amorphous precipitate 
can be avoided by this chromatographic pro- 
cedure. In addition, to decreasing ionic strength, 
pH shifts and decreasing concentrations of organic 
solvents (or precipitating agents) can also be used 
to generate saturated protein solutions. This 
method allows rapid crystallization of small quan- 
tities of protein and in addition the possibility for 
fast optimization of the crystallization conditions. 
Since the capacity of the columns is very high, also 
large quantities of a protein can be purified and 
crystallized in one step by the described procedure. 
Although in our approach easily crystallizable pro- 
teins as lysozyme and a-chymotrypsin were used, 
we could demonstrate in the case of insulin that 
this method considerably accelerates the crystalli- 
zation process. 
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